Authors
Loading...
Analysis identifies mtDNA variants and mutation burden linked to breast cancer risk, highlighting potential biomarkers.
Pérez-Amado et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: